2010
DOI: 10.1017/s0029665110000364
|View full text |Cite
|
Sign up to set email alerts
|

Differential effect of Bifidobacterium species on cytokine production in a Caco-2/PBMC co-culture system

Abstract: Bifidobacterium species present in the gut microbiota have shown capacity to modulate cytokine production by intestinal epithelial cells, monocyte derived dendritic cells and peripheral blood mononuclear cells (PBMC) in in vitro experiments (1,2) . These findings may confer them the potential to be used as probiotics in the prevention and treatment of pathologies with underlying immune alterations, such as inflammatory bowel diseases, allergy and celiac disease.The aim of this study was to evaluate the effect … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…To better understand immunological responses, the co-culture system of IECs and peripheral blood mononuclear cells may be applied for studying cytokine modulation by different bacteria (Parlesak et al, 2004;Pozo et al, 2010;Pozo-Rubio et al, 2011) and could give valuable insight into immune-modulatory effects of synbiotics before testing in humans, which is especially relevant for at-risk groups such as premature infants, elderly, immunocompromised individuals suffering from, e.g., inflammatory bowel diseases.…”
Section: Cell Assaysmentioning
confidence: 99%
“…To better understand immunological responses, the co-culture system of IECs and peripheral blood mononuclear cells may be applied for studying cytokine modulation by different bacteria (Parlesak et al, 2004;Pozo et al, 2010;Pozo-Rubio et al, 2011) and could give valuable insight into immune-modulatory effects of synbiotics before testing in humans, which is especially relevant for at-risk groups such as premature infants, elderly, immunocompromised individuals suffering from, e.g., inflammatory bowel diseases.…”
Section: Cell Assaysmentioning
confidence: 99%